StockData
Zimmer Biomet Holdings, Inc. logo

Zimmer Biomet Holdings, Inc. (ZBH) company profile

ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3018% below fair value
$102.09+0.68 (+0.67%)

Close on Nov 17, 2026Market cap $19.47BP/E 24.8Yield 0.94%

About Zimmer Biomet

Orthopedic, Prosthetic & Surgical Appliances & Supplies, SIC 3842

The provided excerpt consists solely of raw XBRL taxonomy tags, accounting data, and SEC filing metadata without explanatory narrative detailing the entity's core operations or commercial activities. Inferred from product line and segment identifiers, the company operates in medical products and devices, featuring offerings and operating segments associated with knees, hips, surgical equipment, bone cement, and healthcare data technology. The provided text contains no details or statements identifying its end users or customers.

Regarding operational scale and physical presence, the text includes no disclosures concerning facility counts, store counts, employee figures, or headquarters location. Geographic scope is noted purely through regional segment designations and country references, specifically including the Americas, EMEA, Asia Pacific, the United States, and China, in addition to mentions of Swiss and European debt obligations.

Summary of the business section of Zimmer Biomet's latest annual report, written by StockData.

Company profile

Company

Legal name
Zimmer Biomet Holdings, Inc.
Founded
1927
Headquarters
Warsaw, IN
Address
345 East Main Street 46580
Phone
(574) 267-6131
Employees
17,000, Dec 31, 2025
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
PricewaterhouseCoopers LLP, Chicago, Illinois

Stock & identifiers

Ticker
ZBH
Former tickers
ZMH until Nov 9, 2015
Exchange
NYSE
IPO date
Jul 25, 2001
Shares outstanding
191M, Jul 30, 2026
Public float
$18.02B, Jun 30, 2025
Filer category
Large accelerated filer
SEC CIK
1136869
CUSIP
98956P102
ISIN
US98956P1021
FIGI
BBG000BKPL53
Share class FIGI
BBG001S7DQJ9
LEI
2P2YLDVPES3BXQ1FRB91
EIN
13-4151777

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Ivan TornosChairman, President and CEO, Director83,432
Gary Craig CampbellPresident, Americas2,174
Brian Matthew HatcherPresident, Recon, SET, CMFT5,988
Kevin R. ThornalGrp Pres-Global Business0
Chad F. PhippsSee remarks below.65,231
Chintan DesaiPresident, APAC–
Jehanzeb NoorSee remarks below.5,151
Sang YiGroup President, Asia Pacific27,251
Paul A. StellatoVP, Controller, CAO5,257
Lori WinklerSVP and CHRO10,224
Suketu UpadhyayExec VP, CFO69,485
Zuilen Wilfred VanGroup Pres, EMEA30,652
Mark BezjakPresident, Americas13,772
Rachel EllingsonChief Administrative Officer11,906
Robert HagemannDirector4,000
Maria Teresa HiladoDirector1,650
Arthur J. HigginsDirector2,900
Sreelakshmi KolliDirector1,000
Michael J. FarrellDirector2,000
Louis ShapiroDirector–
Devdatt KurdikarDirector–
Syed A. JafryDirector4,060
Betsy J. BernardDirector5,271
Christopher B. BegleyDirector3,540

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$16.11M$12.57M$6.11M$63$127
FY2024$14.99M$9.24M$3.89M$73$117
FY2023
Mr Hanson
$12.76M-$19.16M$5.02M$83$106
FY2023
Mr Tornos
$10.19M$10.29M$5.02M$83$106
FY2022
Mr Hanson
$16.45M$20.50M$4.69M$87$97
FY2022
Mr Tornos
$0$0$4.69M$87$97

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsIncentive payOtherTotalvs. prior year
Ivan Tornos
Chairman, President and CEO
$1.28M–$12.00M$2.42M$403.84K$16.11M+7%
Suketu Upadhyay
CFO and EVP - Finance, Operations and Supply Chain
$906.78K–$4.00M$1.14M$163.28K$6.21M+6%
Kevin Thornal
Group President, Global Businesses and the Americas
$405.39K–$5.30M$505.28K–$6.21M–
Jehanzeb Noor
SVP, Chief Strategy, Business Development, Innovation and Transformation Officer
$683.00K$1.12M$5.10M$730.91K$244.57K$7.87M–
Wilfred van Zuilen
Group President, EMEA
$743.15K–$2.00M$730.33K$665.88K$4.14M+19%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we employed approximately 17,000 employees worldwide, including approximately 2,000 employees dedicated to research and development.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?